Recent highlights of Chinese medicine for advanced lung cancer.
10.1007/s11655-016-2736-2
- Author:
Xi-Ran HE
1
;
Shu-Yan HAN
1
;
Ping-Ping LI
2
Author Information
1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Peking University Cancer Hospital and Institute, Beijing, 100142, China.
2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Peking University Cancer Hospital and Institute, Beijing, 100142, China. pplma123@sina.com.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
advanced lung cancer;
clinical trials;
experimental researches;
latest progress
- From:
Chinese journal of integrative medicine
2017;23(5):323-330
- CountryChina
- Language:English
-
Abstract:
Owing to its unique superiority in improving quality of life and prolonging survival time among advanced lung cancer patients, Chinese medicine (CM) has, in recent years, received increased attentions worldwide. We utilized a bibliometric statistical method based on MEDLINE/GoPubMed to conduct a comprehensive analysis of the current application status of CM in lung cancer, by including annual and accumulated publications, origin distribution of countries and journals, and keywords with a higher frequency score. Then the relevant clinical trials and mechanistic studies were systematically summarized within the field according to research types. We have raised potential problems and provided potentially useful reference information that could guide similar studies in the future. The basic experimental results are highly consistent with clinical trials, leading us to conclude that CM can offer better overall therapeutic benefits when used in combination with routine Western medicine for patients with advanced lung cancer.
